Veradermics

NYSE: MANE · SEC EDGAR filings

Results on file1
Average 24h move+41.51%across 1 result with a complete 24h price
1 resultVeradermics
Met endpoint

VDPHL01

Phase 2/3 n=480 Androgenetic Alopecia

Veradermics MANE

24h stock move +41.51%

For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.